MA XIUPING – Trademark Portfolio

Entity Type: 01

MA XIUPING holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EOPZOL, DOURAMI, and VICUKIE. The owner is based in Jiang Xi.

No.46, LouQian,

ZhongBu, LePing,

Jiang Xi 333300 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DOURAMI
DOURAMI
Registered 2022
VICUKIE
VICUKIE
Registered 2021
EOPZOL
EOPZOL
Registered 2020

Trademark Classifications

MA XIUPING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

21
Housewares (2 filings)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does MA XIUPING have?

MA XIUPING has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does MA XIUPING file in?

MA XIUPING files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 21 (Housewares). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MA XIUPING's most well-known trademarks?

MA XIUPING's registered trademark portfolio includes well-known marks such as EOPZOL, DOURAMI, and VICUKIE. These are among 3 currently registered trademarks in the portfolio.

What is MA XIUPING's trademark registration success rate?

MA XIUPING has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.